3 4 The NOBILITY trial was conducted to test the hypothesis that enhanced B-cell depletion with obinutuzumab would increase the rate of CRR when added to background standard of care compared with ...

To really control light and privacy, double blinds are a must. The trick with roller blinds is to select them ... Tucked neatly into your window frames, honeycomb blinds – also known as cellular ...

The ICMR has formalized a Memorandum of Agreement (MoA) with Zydus for a Phase IIa double-blind, randomized, ...

It offers a variety of products, including faux wood, cellular, mini, vertical, vinyl and wood blinds. Shades are also available in cellular, roller, Roman, simply sheer, soft Roman and woven wood ...

CIRM funded the research that developed this technology and now this Phase 1 trial will test this stem cell directed treatment in people with osteoarthritis of the knee, hopefully slowing down or even ...

Winterizing windows helps you stay warm and cozy while saving money on energy bills and protecting your windows. For drafty ...

ICMR partners with Zydus Lifesciences for Desidustat phase-2 trials in sickle cell disease patients, aiming for innovative ...

If you’re looking to cut your heat and cooling costs, you might consider a roller blind in an energy-efficient honeycomb fabric (also known as cellular fabric ... making it suitable for both ...

Don’t want cords dangling down, or don’t want to fiddle with them every morning and night? Your roller blinds can be automated with the addition of a motorised roller, perfect for those hard to reach ...

The Indian Council of Medical Research (ICMR) on Monday announced a partnership with domestic pharma giant Zydus Lifesciences ...

Zydus Lifesciences has formalized the Memorandum of Agreement (MoA) with Indian Council of Medical Research (ICMR) to initiate Phase 2 clinical trials of Desidustat in patients with Sickle Cell ...

STOCKHOLM, SWEDEN, October 21, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines, has presented positive clinical safety and immunogenicity ...